Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis-related genes with post-transcriptional regulation mechanisms in hepatocellular carcinoma determined by bioinformatics and experimental validation. | Ann Transl Med | 2022 | 36660631 | PubTator, text mining | PubMed |
| Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer. | Transl Cancer Res | 2022 | 36644186 | PubTator, text mining | PubMed |
| Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival. | Front Oncol | 2022 | 36620557 | PubTator, text mining | PubMed |
| Impact of m6A demethylase (ALKBH5, FTO) genetic polymorphism and expression levels on the development of pulmonary tuberculosis. | Front Cell Infect Microbiol | 2022 | 36619747 | PubTator, text mining | PubMed |
| Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression. | Front Immunol | 2022 | 36618403 | PubTator, text mining | PubMed |
| Prognostic Values of METTL3 and Its Roles in Tumor Immune Microenvironment in Pan-Cancer. | J Clin Med | 2022 | 36614956 | PubTator, text mining | PubMed |
| METTL3-Mediated lncSNHG7 m6A Modification in the Osteogenic/Odontogenic Differentiation of Human Dental Stem Cells. | J Clin Med | 2022 | 36614914 | PubTator, text mining | PubMed |
| The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma. | Int J Mol Sci | 2022 | 36614082 | PubTator, text mining | PubMed |
| Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer. | Int J Mol Sci | 2022 | 36613528 | PubTator, text mining | PubMed |
| Corrigendum: Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance. | Front Immunol | 2022 | 36605201 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review. | Cardiovasc Diagn Ther | 2022 | 36605077 | PubTator, text mining | PubMed |
| Dynamic regulation and key roles of ribonucleic acid methylation. | Front Cell Neurosci | 2022 | 36601431 | PubTator, text mining | PubMed |
| Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer. | Front Immunol | 2022 | 36601127 | PubTator, text mining | PubMed |
| Human Endogenous Retroviruses: Friends and Foes in Urology Clinics. | Int Neurourol J | 2022 | 36599336 | PubTator, text mining | PubMed |
| Prognostic and therapeutic implication of m6A methylation in Crohn disease. | Medicine (Baltimore) | 2022 | 36595818 | PubTator, text mining | PubMed |
| The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in rectosigmoid cancer. | Medicine (Baltimore) | 2022 | 36595765 | PubTator, text mining | PubMed |
| Joint analysis of m6A and mRNA expression profiles in the testes of idiopathic nonobstructive azoospermia patients. | Front Endocrinol (Lausanne) | 2022 | 36589848 | PubTator, text mining | PubMed |
| Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma. | Front Mol Biosci | 2022 | 36589239 | PubTator, text mining | PubMed |
| m6A regulator-mediated methylation modification patterns and immune microenvironment infiltration characterization in osteoarthritis. | BMC Med Genomics | 2022 | 36585683 | PubTator, text mining | PubMed |
| N6-methyladenosine modification of viral RNA and its role during the recognition process of RIG-I-like receptors. | Front Immunol | 2022 | 36582239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=78